Skip to main content
Screener/Healthcare/Biotechnology

MAZE — Maze Therapeutics, Inc.

NASDAQ
$28.73+6.34 (+28.32%)
Small CapUnder $50HealthcareHigh Beta
$21.95
$53.65
$24.50
$29.40
EPS (TTM)$-2.75
P/E Ratio-8.51
Dividend Yield—
Market Cap$1.34B
Volume3.02M
Prev Close$22.39
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$20.0M-$24.2M$-0.4597.8%-121.0%
Q4 '25$0-$34.6M$-0.87——
Q3 '25$0-$30.1M$-0.66——
Q2 '25$0-$33.7M$-0.77——
Q1 '25$0-$32.8M$-0.75——
Q4 '24$0-$29.6M$-0.11——
Q3 '24$2.5M-$24.8M$-0.06100.0%-990.1%
Q2 '24$165.0M$139.1M$0.98100.0%84.3%
Get Your Daily Market Recap